Podcasts

Episode 10 | Long Term Survivorship: Thriving with Metastatic Lung Cancer

In this episode, Lillian Leigh, Dr Sarah Heynemann and Mary Duffy discuss the challenges associated with long term survivorship.

Long Term Survivorship: Thriving with Metastatic Lung Cancer

Episode Summary

In this episode, Lillian Leigh, Dr Sarah Heynemann and Mary Duffy discuss the challenges associated with long term survivorship.

This TOGA Podcast focuses on thriving with lung cancer and overcoming the challenges associated with long term survivorship and lung cancer. The past decade has seen significant advances in the management of metastatic NSCLC with the advent of multiple targeted therapies, immunotherapy approaches and combination approaches and associated improvements in survival outcomes for patients. There is an emerging cohort of patients with advanced NSCLC who experience long periods of disease control whilst on these treatments.

Traditionally survivorship has referred to the care of or issues for patients following curative treatment of early-stage disease. However, due to the recent advances described here, there is a compelling need to begin addressing the issues faced by long term metastatic disease ’survivors’.

Show Hosts

This episode’s host are:

  • Lillian Leigh, Membership and Advocacy Chair, TOGA; long-term survivor of lung cancer
  • Dr Sarah Heynemann, Medical Oncologist
  • Mary Duffy, Lung Cancer Clinical Nurse Consultant, Lung MDT, Peter MacCallum Cancer Institute

Play Episode 10 | Long Term Survivorship: Thriving with Metastatic Lung Cancer

More Podcasts

A conversation with Associate Professor Tom John and Professor Ben Solomon where they discuss the increased survival benefits for patients with oncogene driven lung cancer
In this Podcast, Mark Scott talks with Alexandra Golledge about her challenges in diagnosis, searching for the best treatments available, living in a regional area
Prof Nick Pavlakis and Prof Emily Stone join discuss the remarkable advances in screening, diagnosing and treating lung cancer that occurred during 2020.
Dorothy Keefe, CEO of Cancer Australia and Mark Scott discuss the COVID impact on diagnosing and treating lung cancer patients.
A fireside chat with Prunella Blinman, Shankar Siva and our three Preceptees: Anna Lawless, Abhijit Pal and Melanie Rabbets about their experiences, their learnings, what
In this episode, Prof Anna Nowak and A/Prof Steven Kao discuss the emerging treatments for mesothelioma patients and the DREAM3R trial.